Whole Cannabis Extract May Beat THC Alone for Metabolic Health, Mouse Study Suggests

Regular cannabis users often weigh less and show lower rates of type 2 diabetes than you might expect for a drug famous for triggering the munchies. Scientists have struggled to explain that paradox — until a new preclinical study suggested the answer may lie not in THC alone, but in the wider mix of compounds found in the whole plant.

Published in The Journal of Physiology, the research compared purified delta-9 THC with a whole cannabis extract containing the same amount of THC plus other naturally occurring plant compounds. Both treatments helped obese mice shed weight. What happened to their metabolism, however, was strikingly different.

Weight loss without metabolic recovery

Led by Nicholas V. DiPatrizio at the University of California, Riverside, the team used a mouse model designed to mimic human dietary obesity. Mice given THC alone lost a meaningful amount of weight — but their bodies still struggled to regulate blood sugar, a core problem in type 2 diabetes.

In plain terms, the animals got lighter without getting metabolically healthier. Glucose control remained impaired, much like some people who lose weight but still live with insulin resistance or prediabetes.

Mice treated with the whole cannabis extract told a different story. They lost comparable weight and showed signs that their metabolic systems were recovering. The researchers linked that improvement to better communication between fat tissue and the pancreas — the organs that must work together to keep blood sugar in check.

The fat-to-pancreas connection

The paper focuses on something called adipoinsular dysfunction — essentially, a breakdown in the signalling pathway between fat cells and the pancreas.

In a healthy body, fat tissue releases chemical signals that help the pancreas release the right amount of insulin. Obesity and type 2 diabetes can disrupt that conversation. Fat and pancreas stop coordinating properly, and blood sugar regulation suffers even if someone is losing weight on the scales.

According to the study, whole cannabis extract appeared to restore that fat-to-pancreas signalling more effectively than THC on its own. The extract group not only lost weight but showed improved glucose regulation — suggesting the metabolic architecture was beginning to normalise.

"This suggests that THC alone is not responsible for the metabolic benefits associated with cannabis use," DiPatrizio said. "Other compounds in the plant appear to play a critical role."

DiPatrizio directs the UCR Center for Cannabinoid Research. His team has not yet identified which specific non-THC compounds drive the effect — CBD, minor cannabinoids, terpenes and other plant constituents all remain candidates for follow-up work.

What the researchers are — and are not — saying

The findings have generated attention because they touch on the so-called entourage effect — the idea that cannabis compounds may work differently together than in isolation. Here, that idea is being tested at the level of metabolic biology rather than anecdotal reports about product types.

But the authors were explicit about the limits. This is animal research, not a human clinical trial. Mouse metabolism differs from ours in important ways, and nothing in the paper supports using cannabis to treat obesity or diabetes.

"We're not suggesting people should use cannabis to manage weight or diabetes," DiPatrizio told UC Riverside.

He added that clinicians, researchers and policymakers should pay close attention as cannabis use grows and laws change: "We need evidence-based approaches to fully understand both the risks and potential benefits of cannabis and its components."

Looking ahead, DiPatrizio aims to isolate non-psychoactive compounds that might offer metabolic benefits without THC's intoxicating effects — a step that would be necessary before any serious medical application could be considered.

Why this matters for UK readers

Britain's medical cannabis market is dominated by THC- and CBD-focused products, many of them highly refined rather than whole-plant preparations. Recreational consumers, where legally available abroad, often reach for high-THC concentrates for the same reason: potency and predictability.

This study does not tell anyone which product to choose. It does, however, add a mechanistic hint that formulation may matter for metabolic outcomes — and that stripping cannabis down to THC alone might miss effects tied to the rest of the plant matrix.

Population studies have long noted lower obesity and diabetes rates among regular cannabis users despite increased appetite. This paper offers one possible biological explanation, while leaving the clinical picture firmly open.

Important caveats

The research was funded by the US National Institutes of Health and the Tobacco-Related Disease Research Program. It was conducted in obese mice fed a diet meant to reflect human eating patterns, not in people using street cannabis or prescribed oils.

The whole-plant extract used in the study was not a branded consumer product, and its exact composition beyond matched THC levels has not been broken down for public replication. Until specific compounds are identified and tested, attributing the benefit to "the entourage effect" remains a working hypothesis rather than a proven mechanism.

Anyone managing weight, blood sugar or diabetes should treat headlines about this study with caution. The practical message is to discuss cannabis use openly with a clinician — and not to assume that because a mouse study looked promising, a high-THC vape or edible will deliver the same metabolic result.

Reporting based on Δ9 Tetrahydrocannabinol and cannabis extracts differentially improve adipoinsular dysfunction in diet-induced obesity, published in The Journal of Physiology, May 2026.